We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

By LabMedica International staff writers
Posted on 04 Jul 2025

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. More...

Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric leukemia under Europe’s IVDR framework. Now available for clinical use, this test enhances diagnostic accuracy, enabling more personalized treatment and better outcomes for children with this common cancer. This unique and new test is set to reshape the way BCP-ALL samples can be analyzed. It includes both gene expression subtype classification of B-cell leukemias and gene fusion analysis support.

The regulatory approved test benefits from machine learning based subtype classification with enhanced subtype coverage and reduces the risk of escalated and expensive treatments. An additional 7% of samples are subtyped using gene expression profiles, enabling detection of DUX4-rearranged and ETV6::RUNX1-like subtypes. The BCP-ALL test simplifies lab work by utilizing standard wetlab and standard kits, while combining gene expression-based subtyping and gene fusions in one clinical report. The robust test utilizes up to three different gene fusion callers for improved coverage, and gene fusions are presented in Tiers including all detected fusions.

The cost-effective test can replace FISH tests with significant cost savings. Additionally, Whole Transcriptome Sequencing (WTS) allows all fusions to be clinically annotated, with future updates in software rather than in lab workflows. By integrating advanced genetic analysis with user-friendly software, the test empowers diagnostic laboratories and clinicians to make informed decisions for enhanced patient care.

Related Links:
Qlucore 


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Host Response Immunoassay Test
MeMed BV
New
Drug Test Kit
DrugCheck 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.